For: | Shi HJ, Jin C, Fu DL. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability. World J Gastroenterol 2016; 22(45): 10024-10037 [PMID: 28018110 DOI: 10.3748/wjg.v22.i45.10024] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i45/10024.htm |
Number | Citing Articles |
1 |
Satoshi Yasuda, Minako Nagai, Taichi Terai, Yuichiro Kohara, Masayuki Sho. Essential updates 2021/2022: Surgical outcomes of oligometastasis in pancreatic ductal adenocarcinoma. Annals of Gastroenterological Surgery 2023; 7(3): 358 doi: 10.1002/ags3.12655
|
2 |
Milena Muzzolini, Renato Lupinacci, Jean-Baptiste Bachet, Donia Lassoued, Alain Sauvanet, Sébastien Gaujoux. Should liver metastases of pancreatic adenocarcinoma be resected?. Journal of Visceral Surgery 2024; 161(2): 129 doi: 10.1016/j.jviscsurg.2023.12.006
|
3 |
Wei Zhang, Lichen Ji, Xugang Zhong, Senbo Zhu, Yi Zhang, Meng Ge, Yao Kang, Qing Bi. Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study. Frontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.884349
|
4 |
Xinyu Dou, Jiaona Xi, Gaozan Zheng, Guangming Ren, Ye Tian, Hanjun Dan, Zhenyu Xie, Liaoran Niu, Lili Duan, Ruikai Li, Hongze Wu, Fan Feng, Jianyong Zheng. A nomogram was developed using clinicopathological features to predict postoperative liver metastasis in patients with colorectal cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(15): 14045 doi: 10.1007/s00432-023-05168-1
|
5 |
Willem Niesen, Florian Primavesi, Silvia Gasteiger, John Neoptolemos, Thilo Hackert, Stefan Stättner. Surgical and local therapeutic concepts of oligometastatic pancreatic cancer in the era of effective chemotherapy. European Surgery 2019; 51(3): 153 doi: 10.1007/s10353-019-0589-6
|
6 |
Yu-qing Du, Xiu-mei Bai, Wei Yang, Zhong-yi Zhang, Song Wang, Wei Wu, Kun Yan, Min-hua Chen. Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastasis from pancreatic adenocarcinoma. International Journal of Hyperthermia 2022; 39(1): 517 doi: 10.1080/02656736.2022.2048907
|
7 |
Shruti Koti, Lyudmyla Demyan, Gary Deutsch, Matthew Weiss. Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability. Annals of Surgical Oncology 2024; 31(6): 4031 doi: 10.1245/s10434-024-15129-8
|
8 |
Tianqiang Jin, Chaoliu Dai, Feng Xu. Surgical and local treatment of hepatic metastasis in pancreatic ductal adenocarcinoma: recent advances and future prospects. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920933034
|
9 |
Huaqiang Ouyang, Weidong Ma, Ti Zhang, Fang Liu, Lujun Zhao, Minghui Fang, Manman Quan, Zhanyu Pan. Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocarcinoma and synchronous liver metastases. Pancreatology 2018; 18(8): 983 doi: 10.1016/j.pan.2018.09.015
|
10 |
Felice Giuliante, Elena Panettieri, Andrea Campisi, Alessandro Coppola, Maria Vellone, Agostino M. De Rose, Francesco Ardito. Treatment of oligo-metastatic pancreatic ductal adenocarcinoma to the liver: is there a role for surgery? A narrative review. International Journal of Surgery 2024; 110(10): 6163 doi: 10.1097/JS9.0000000000001665
|
11 |
Jinghui Lin, Yiwen Wu, Xinpeng Deng, Shengjun Zhou, Yuchun Liu, Junjun Zhang, Yiyong Zeng, Xianru Li, Xiang Gao, Bin Xu, Chenhui Zhou. Application of intraoperative infrared thermography in bypass surgery for adult moyamoya syndrome: A preliminary study. Frontiers in Neurology 2023; 14 doi: 10.3389/fneur.2023.1174072
|
12 |
An-An Li, Zhi-Yuan Cao, Jia-Ming Liu, Shan-Hu Huang, Zhi-Li Liu. The risk factors for bone metastases in patients with colorectal cancer. Medicine 2018; 97(40): e12694 doi: 10.1097/MD.0000000000012694
|
13 |
Yuzhou Huang, Shurui Zhou, Yanji Luo, Jinmao Zou, Yaqing Li, Shaojie Chen, Ming Gao, Kaihong Huang, Guoda Lian. Development and validation of a radiomics model of magnetic resonance for predicting liver metastasis in resectable pancreatic ductal adenocarcinoma patients. Radiation Oncology 2023; 18(1) doi: 10.1186/s13014-023-02273-w
|
14 |
Zhouyu Ning, Ying Zhu, Lin Xie, Xia Yan, Yongqiang Hua, Zhiqiang Meng. Exploring the efficacy and safety of drug-eluting beads transarterial chemoembolization in pancreatic cancer liver metastasis. British Journal of Radiology 2024; 97(1157): 1010 doi: 10.1093/bjr/tqae059
|
15 |
Meng Lu, Chun‑Hui Yuan, Ling‑Fu Zhang, Lian‑Yuan Tao, Ying Peng, Li‑Mei Guo, Gang Li, Dian‑Rong Xiu. Pathological analysis of the superior mesenteric artery boundary in preoperative computed tomography of resectable pancreatic head adenocarcinoma. Oncology Letters 2019; doi: 10.3892/ol.2019.10269
|
16 |
Thomas Seufferlein, Julia Mayerle, Stefan Boeck, Thomas Brunner, Thomas J. Ettrich, Lars Grenacher, Thomas Mathias Gress, Thilo Hackert, Volker Heinemann, Angelika Kestler, Marianne Sinn, Andrea Tannapfel, Ulrich Wedding, Waldemar Uhl. S3-Leitlinie Exokrines Pankreaskarzinom – Version 3.1. Zeitschrift für Gastroenterologie 2024; 62(10): 1724 doi: 10.1055/a-2338-3716
|
17 |
Thomas Seufferlein, Julia Mayerle, Stefan Böck, Thomas Brunner, Thomas J. Ettrich, Lars Grenacher, Thomas Mathias Gress, Thilo Hackert, Volker Heinemann, Angelika Kestler, Marianne Sinn, Andrea Tannapfel, Ulrich Wedding, Waldemar Uhl. S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL. Zeitschrift für Gastroenterologie 2022; 60(11): e812 doi: 10.1055/a-1856-7346
|
18 |
Tatsuma Sakaguchi, Roberto Valente, Kimitaka Tanaka, Sohei Satoi, Marco Del Chiaro. Surgical treatment of metastatic pancreatic ductal adenocarcinoma: A review of current literature. Pancreatology 2019; 19(5): 672 doi: 10.1016/j.pan.2019.05.466
|
19 |
Thomas Seufferlein, Julia Mayerle, Stefan Böck, Thomas Brunner, Thomas J. Ettrich, Lars Grenacher, Thomas Mathias Gress, Thilo Hackert, Volker Heinemann, Angelika Kestler, Marianne Sinn, Andrea Tannapfel, Ulrich Wedding, Waldemar Uhl. S3-Leitlinie zum exokrinen Pankreaskarzinom – Kurzversion 2.0 – Dezember 2021, AWMF-Registernummer: 032/010OL. Zeitschrift für Gastroenterologie 2022; 60(06): 991 doi: 10.1055/a-1771-6811
|
20 |
Takumi Funo, Daisuke Hashimoto, So Yamaki, Kazuki Matsumura, Hidetaka Miyazaki, Yuki Matsui, Denys Tsybulskyi, Nguyen Thanh Sang, Xu Yaolin, Sohei Satoi. Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based chemotherapy followed by olaparib. Surgical Case Reports 2024; 10(1) doi: 10.1186/s40792-024-01975-x
|
21 |
James M Halle-Smith, Sarah Powell-Brett, Keith Roberts, Nikolaos A Chatzizacharias. Resection of isolated liver oligometastatic disease in pancreatic ductal adenocarcinoma: Is there a survival benefit? A systematic review. World Journal of Gastrointestinal Surgery 2023; 15(7): 1512-1521 doi: 10.4240/wjgs.v15.i7.1512
Abstract(487) |
Core Tip(500) |
Full Article(HTML)(1637)
|
Full Article with Cover (PDF)-1863K(85)
|
Full Article (Word)-348K(83)
|
Audio-559K(1)
|
Peer-Review Report-230K(73)
|
Answering Reviewers-101K(67)
|
Supplementary Material-89K(65)
|
Full Article (PDF)-1158K(157)
|
Full Article (XML)-130K(63)
|
Times Cited (6)
|
Total Visits (6161)
|
Open
|
22 |
Maximilian Brunner, Christian Krautz, Georg F Weber, Robert Grützmann. Bessere Therapie des Pankreaskarzinoms durch radikalere Chirurgie?. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie 2022; 147(02): 173 doi: 10.1055/a-1766-7643
|
23 |
Vincenzo D'Ambra, Claudio Ricci, Carlo Ingaldi, Laura Alberici, Margherita Minghetti, Riccardo Casadei. Stage IV pancreatic ductal adenocarcinoma (PDAC) with synchronous liver metastasis: are there survival benefits in liver resection? A systematic review and meta-analysis. European Journal of Surgical Oncology 2025; 51(5): 109598 doi: 10.1016/j.ejso.2025.109598
|
24 |
Milena Muzzolini, Renato Lupinacci, Jean-Baptiste Bachet, Donia Lassoued, Alain Sauvanet, Sébastien Gaujoux. Faut-il réséquer les métastases hépatiques d’adénocarcinome du pancréas ?. Journal de Chirurgie Viscérale 2024; 161(2): 141 doi: 10.1016/j.jchirv.2023.09.007
|
25 |
J. Gao, Y. Bai, F. Miao, X. Huang, M. Schwaiger, A. Rominger, B. Li, H. Zhu, X. Lin, K. Shi. Prediction of synchronous distant metastasis of primary pancreatic ductal adenocarcinoma using the radiomics features derived from 18F-FDG PET and MRI. Clinical Radiology 2023; 78(10): 746 doi: 10.1016/j.crad.2023.06.011
|
26 |
Thomas Seufferlein, Julia Mayerle, Stefan Boeck, Thomas Brunner, Thomas J. Ettrich, Lars Grenacher, Thomas Mathias Gress, Thilo Hackert, Volker Heinemann, Angelika Kestler, Marianne Sinn, Andrea Tannapfel, Ulrich Wedding, Waldemar Uhl. S3-Leitlinie Exokrines Pankreaskarzinom – Version 3.1. Zeitschrift für Gastroenterologie 2024; 62(10): e874 doi: 10.1055/a-2338-3533
|
27 |
Sergio Pedrazzoli. Currently Debated Topics on Surgical Treatment of Pancreatic Ductal Adenocarcinoma: A Narrative Review on Surgical Treatment of Borderline Resectable, Locally Advanced, and Synchronous or Metachronous Oligometastatic Tumor. Journal of Clinical Medicine 2023; 12(20): 6461 doi: 10.3390/jcm12206461
|
28 |
Michael Ghadimi, Uwe Pelzer, Marc G. Besselink, Jens Siveke, Ralph Telgmann, Rickmer Braren, Hanneke Wilmink, Marie Crede, Alexander Koenig, Ute Koenig, Sven Thorsten Liffers, Kai Antweiler, Bas Uijterwijk, Hanna Seppanen, Arno Nordin, Pauli Puolakkainen, Olav F. Dajani, Knut Jørgen Labori, Mia Johansson, Svein Olav Bratlie, Tim Friede, Peter Jo. Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-13573-7
|
29 |
Noah Clements, Jeremy Gaskins, Robert C. G. Martin. Surgical Outcomes in Stage IV Pancreatic Cancer with Liver Metastasis Current Evidence and Future Directions: A Systematic Review and Meta-Analysis of Surgical Resection. Cancers 2025; 17(4): 688 doi: 10.3390/cancers17040688
|
30 |
Qingyan Kong, Fei Teng, Hang Li, Zheyu Chen. Radical resection benefits patients suffering pancreatic ductal adenocarcinoma with liver oligometastases. Annals of Surgical Treatment and Research 2024; 106(1): 51 doi: 10.4174/astr.2024.106.1.51
|
31 |
Chu-Feng Wang, Sheng-Jia Peng, Rong-Qiang Liu, Ya-Jie Yu, Qian-Min Ge, Rong-Bin Liang, Qiu-Yu Li, Biao Li, Yi Shao, Michele Malaguarnera. The Combination of CA125 and NSE Is Useful for Predicting Liver Metastasis of Lung Cancer. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/8850873
|
32 |
Daisuke Hashimoto, Sohei Satoi, Tsutomu Fujii, Masayuki Sho, Jin He, Thilo Hackert, Marco Del Chiaro, Jin-Young Jang, Aiste Gulla, Yoo-Seok Yoon, Yan-Shen Shan, Wenhui Lou, Roberto Valente, Junji Furuse, Atsushi Oba, Minako Nagai, Taichi Terai, Haruyoshi Tanaka, Ayano Sakai, Tomohisa Yamamoto, So Yamaki, Ippei Matsumoto, Yoshiaki Murakami, Kyoichi Takaori, Yoshifumi Takeyama. Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? A position paper by experts in pancreatic surgery at the Joint Meeting of the International Association of Pancreatology (IAP) & the Japan Pancreas Society (JPS) 2022 in Kyoto. Pancreatology 2023; 23(6): 682 doi: 10.1016/j.pan.2023.07.005
|
33 |
C.-S. Leonhardt, T. Stamm, T. Hank, G. Prager, O. Strobel. Defining oligometastatic pancreatic cancer: a systematic review and critical synthesis of consensus. ESMO Open 2023; 8(6): 102067 doi: 10.1016/j.esmoop.2023.102067
|
34 |
Wentao Zhou, Dansong Wang, Wenhui Lou. Current Role of Surgery in Pancreatic Cancer With Synchronous Liver Metastasis. Cancer Control 2020; 27(1) doi: 10.1177/1073274820976593
|